July 6, 2021

LevitaMagnetics400x275Levita Magnetics, which is developing a surgical robotics platform , has announced its first robotic-assisted surgical procedure with its newest system, the Levita Robotic Platform. The first case was a reduced-incision laparoscopic cholecystectomy (gallbladder removal) completed by Dr. Ignacio Robles, a surgeon at Clinica INDISA in Santiago, Chile, as part of a current clinical study of the system.

The new robotic platform aims to deliver the clinical benefits of the company’s first commercial product, the Levita Magnetic Surgical System, including less pain, faster recovery, and fewer scars for patients. The platform helps improve visualization, maintain surgical control of instruments, and increase hospital efficiency with fewer assistive personnel required to conduct the procedures, Levita said. WIth a compact footprint, the robotic platform is specially designed for high volume ambulatory or same-day discharge abdominal surgeries. The aim is to increase the volume of high-quality, efficiently performed procedures while improving surgical access to patients, the company added.

“I am pleased to have the opportunity to perform the world’s first procedures using this innovative robotic platform,” said Dr. Robles. “The first surgery was a challenging acute cholecystitis, nevertheless, the procedure went very smoothly and the patient had an outstanding recovery with no complications reported at 30 days post-procedure. Since then, we have performed two additional acute cholecystectomies using the robotic platform, with both patients enrolled and treated on the same day. The combination of Levita’s magnetic technology with a robotic platform shows great promise to improve surgeon control and efficiency during surgical procedures. I’m excited to continue participating in this clinical study to further support the development of this platform.”

The surgical system enables reduced-port laparoscopic surgical procedures designed to minimize the footprint of surgery. The system contains an external magnet placed on the skin that controls a shaftless detachable grasper, enabling instruments to move without the constraints of a fixed-position pivot point. The system is designed to be used to grasp and retract the body and the fundus of the gallbladder in laparoscopic cholecystectomy procedures; the liver in bariatric procedures; the prostate and periprostatic tissue in prostatectomy procedures; and the colon, rectum, and pericolorectal tissue in colorectal procedures to facilitate access and visualization of the surgical site. The device is indicated for use in patients with a body mass index range of 20 to 60 kg/m2, Levita said.

“We are taking magnetic surgery to the next level with this disruptive approach,” said Dr. Alberto Rodriguez-Navarro, a minimally invasive surgeon, and founder and CEO of Levita Magnetics. “Our robotic platform is designed to be the first to enable the clinical benefits of a less invasive procedure with fewer incisions, while allowing the surgeon full control of the platform and surgical instruments directly beside the patient. We believe enabling timely access to needed surgery has a direct impact on the quality of life for patients and may reduce the risk of complications or death due to the underlying disease.”

The company said its goal is to increase the ability of surgeons and hospitals to provide more patients access to better surgical procedures within their communities. The clinical study is continuing and the company plans to submit the robotic platform to the FDA for clearance in late 2021. For more details on the company’s offerings, visit the Levita Magnetics website.